Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02978625
Brief Title: Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers

First Submitted : November 30, 2016
First Submitted that Met QC Criteria : November 30, 2016
First Posted : December 1, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : August 5, 2019
Last Update Posted : August 6, 2019